Remdesivir

Preliminary data from two clinical trials using the antiviral drug remdesivir to treat COVID-19 patients is encouraging, researchers report One trial is providing the drug to patients with moderate illness…

Covid-19 patients who are getting an experimental drug called remdesivir have been recovering quickly, with most going home in days, STAT News reported Thursday after it obtained a video of a…

Remdesivir, a nucleoside analog, works through inhibiting viral replication through competitively inhibiting viral RNA polymerase. The interesting thing about remdesivir is that it has this phosphoramidate attachment to the ribostring,…